IceCure Medical (ICCM)
NASDAQ:ICCM
US Market
Holding ICCM?
Track your performance easily

Icecure Medical (ICCM) Income Statement

131 Followers

Icecure Medical Income Statement

Last quarter (Q ), Icecure Medical's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, Icecure Medical's net income was $―. See Icecure Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.40M$ 3.23M$ 3.08M$ 4.14M$ 3.87M
Cost of Revenue
$ 849.00K$ 1.93M$ -1.64M$ 1.94M$ 1.42M
Gross Profit
$ 550.00K$ 1.30M$ 1.45M$ 2.19M$ 2.44M
Operating Expense
$ 8.93M$ 16.85M$ 18.18M$ 11.92M$ 6.59M
Operating Income
$ -8.38M$ -15.55M$ -16.74M$ -9.72M$ -4.14M
Net Non Operating Interest Income Expense
$ -197.00K$ 924.00K$ -239.00K$ -171.00K$ 412.00K
Other Income Expense
----$ -177.00K
Pretax Income
$ -8.58M$ -14.62M$ -16.98M$ -9.89M$ -3.73M
Tax Provision
--$ -16.95M$ -10.08M-
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -8.58M$ -14.62M$ -16.98M$ -9.89M$ -3.73M
Basic EPS
$ -0.23$ 0.32$ 0.46$ 0.35$ -0.27
Diluted EPS
$ -0.23$ 0.32$ 0.46$ 0.35$ -0.27
Basic Average Shares
$ 73.65M$ 45.64M$ 37.02M$ 28.55M$ 17.13M
Diluted Average Shares
$ 73.65M$ 45.64M$ 37.02M$ 28.55M$ 17.13M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 9.78M$ 18.77M$ 16.54M$ 13.86M$ 8.01M
Net Income From Continuing And Discontinued Operation
$ -8.58M$ -14.62M$ -16.98M$ -9.89M$ -3.73M
Normalized Income
$ -8.58M---$ -3.73M
Interest Expense
$ 197.00K---$ 102.00K
EBIT
$ -8.38M-$ -16.98M$ -9.89M$ -4.14M
EBITDA
$ -8.26M-$ -16.73M$ -9.77M$ -4.08M
Currency in USD

Icecure Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis